$35 million boost for Rona Therapeutics: A new era in RNA medicine begins!
Rona Therapeutics, a clinical-stage company leading the way in nucleic acid drug research and development, has successfully completed a Series A+ financing round, raising $35 ... Read More
Orna Therapeutics acquires ReNAgade Therapeutics, appoints new CEO to lead RNA therapeutics innovation
Orna Therapeutics, a pioneer in the field of circular RNA therapeutics, has officially announced its acquisition of ReNAgade Therapeutics, a company renowned for its significant ... Read More